Furthermore, we have identified that two HDAC inhibitors with distinct structures, TSA and NaBu32, impede lung adenocarcinoma migration via HDAC2 by interacting with YY1, a transcription factor, and deacetylating Cdh1, a tumor suppressor gene33. This evidence concerns the gene HDAC2 and lung adenocarcinoma.